Overview
Current Appointments & Affiliations
Professor of Medicine
·
2018 - Present
Medicine, Medical Oncology,
Medicine
Member of the Duke Cancer Institute
·
2004 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Disparities in treatment delays among metastatic breast cancer patients: insights from nationwide electronic health records, 2011-2022.
Journal Article Breast Cancer Res Treat · April 2025 PURPOSE: While previous research has highlighted treatment delay inequities in early-stage breast cancer and identified potential contributing factors, there is limited research on disparities in treatment delays for metastatic breast cancer (MBC). This st ... Full text Link to item CiteWeb-Based Pain Coping Skills Training (PCST) for Managing Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors: Randomized Controlled Trial Protocol.
Journal Article Contemp Clin Trials · February 2025 BACKGROUND: Aromatase inhibitors (AIs) are a cornerstone of adjuvant systemic therapy for postmenopausal patients with hormone-receptor positive (HR+) breast cancer. Although AIs decrease cancer recurrence rates and improve survival rates, approximately 50 ... Full text Link to item CiteThe Cost-Effectiveness of CDK4/6 Inhibitors in Treating HR+/HER2- Metastatic Breast Cancer Patients in the USA: When Non-medication Expenses are Considered.
Journal Article Clin Drug Investig · February 2025 BACKGROUND AND OBJECTIVE: Cyclin-dependent kinase (CDK)4/6 inhibitors in combination with endocrine therapy (ET) significantly enhance progression-free survival and overall survival in patients diagnosed with HR+/HER2- metastatic breast cancer (MBC). Howev ... Full text Link to item CiteRecent Grants
A randomized phase II trial of adjuvant trastuzumab emtansine (T-DM1) followed by subcutaneous trastuzumab versus paclitaxel in combination with subcutaneous trastuzumab for Stage I HER2-positive breast cancer (ATEMPT 2.0)
Clinical TrialPrincipal Investigator · Awarded by Dana-Farber Cancer Institute · 2023 - 2028Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial
ResearchCo Investigator · Awarded by Northwestern University · 2022 - 2027Evaluating a Patient Navigation Program to Improve Therapy Management for HER2+ Metastatic Breast Cancer Patients Treated with Tucatinib
ResearchCo Investigator · Awarded by Pfizer, Inc. · 2025 - 2026View All Grants
Education, Training & Certifications
Wake Forest University ·
2000
M.S.
Wake Forest University ·
1989
M.D.